作者: D L Harris , P J Weston , J E Harding
DOI: 10.1038/JP.2013.183
关键词:
摘要: Randomized trials are essential for improving outcomes, but researchers can be hesitant about undertaking clinical in newborn babies because of perceived vulnerability the baby and risk increasing parental anxiety. There is a paucity evidence experience. We investigated mothers’ experiences having their participate randomized double-blind placebo-controlled trial soon after birth. Eligible mothers had consented to baby’s participation Sugar Babies Study. Mothers potentially eligible were invited join study antenatally, others approached postnatally. enrolled birth remained 48 h. After 2 weeks interviewed by phone Four hundred eighty-one enrolled, whom 310 (64%) gave consent antenatally. All contacted 477 (99%) interviewed. The majority (458, 96%) reported they would participating again, if another baby, 460 (96%) recommend family friends. Nineteen (4%) did not like heel lance blood tests, which part routine care protocol. Most experience as positive. negative responses related aspects rather than